Denium Therapeutics, Inc - Common Shares (NQ:MNMD)

14.87 +0.99 (+7.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 13, 2026 Add to My Watchlist

Price and Volume

Volume	3,222,101
Open	13.92
Bid (Size)	14.83 (300)
Ask (Size)	14.86 (300)
Prev. Close	13.88
Today's Range	13.83 - 15.20
52wk Range	4.700 - 15.29
Shares Outstanding	38,595,310
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year? ↗

December 24, 2025

Regulatory thaw, political backing, and late-stage data are propelling psychedelic drugmakers into the biotech spotlight — with Compass Pathways and Mind Medicine leading the charge.

Via Stocktwits

MarketBeat’s Top 5 Rated Small-Cap Stocks ↗

December 22, 2025

Via MarketBeat

Performance

YTD	+9.0%	+9.0%
1 Month	+23.1%	+23.1%
3 Month	+21.4%	+21.4%
6 Month	+78.5%	+78.5%
1 Year	+128.9%	+128.9%

More News

MindMed to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 18, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grant

December 15, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

MindMed Announces New Employee Inducement Grants

December 01, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Reports Q3 2025 Earnings Miss Amid Accelerated Clinical Pipeline Spending ↗

November 06, 2025

Via Chartmill

MindMed (MNMD) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Via The Motley Fool

MindMed Reports Q3 2025 Financial Results and Business Updates

November 06, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed to Participate in Upcoming Investor Conferences

November 05, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grant

November 03, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

November 03, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed to Report Q3 2025 Financial Results on November 6, 2025

October 30, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public Offering

October 29, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine (MindMed) Inc. Announces Proposed Public Offering

October 29, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grant

October 14, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

Mind Medicine Analyst Cites Strong Phase 3 Pipeline For Anxiety, Depression ↗

October 13, 2025

Via Benzinga

The Insider Report: Panic Never Pays ↗

October 11, 2025

Via Benzinga

MindMed Announces New Employee Inducement Grants

September 22, 2025

From Mind Medicine Inc.

Via Business Wire

New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)

September 19, 2025

From Mind Medicine (MindMed) Inc.

Via Business Wire

MindMed Announces New Employee Inducement Grants

September 08, 2025

From Mind Medicine Inc.

Via Business Wire

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

September 04, 2025

From Mind Medicine Inc.

Via Business Wire

MindMed to Participate in September Investor Conferences

August 28, 2025

From Mind Medicine Inc.

Via Business Wire

If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today ↗

August 12, 2025

Via The Motley Fool

MindMed Announces New Employee Inducement Grants

August 11, 2025

From Mind Medicine Inc.

Via Business Wire

Frequently Asked Questions

Is Denium Therapeutics, Inc - Common Shares publicly traded?

Yes, Denium Therapeutics, Inc - Common Shares is publicly traded.

What exchange does Denium Therapeutics, Inc - Common Shares trade on?

Denium Therapeutics, Inc - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Denium Therapeutics, Inc - Common Shares?

The ticker symbol for Denium Therapeutics, Inc - Common Shares is MNMD on the Nasdaq Stock Market

What is the current price of Denium Therapeutics, Inc - Common Shares?

The current price of Denium Therapeutics, Inc - Common Shares is 14.87

When was Denium Therapeutics, Inc - Common Shares last traded?

The last trade of Denium Therapeutics, Inc - Common Shares was at 01/13/26 04:00 PM ET

What is the market capitalization of Denium Therapeutics, Inc - Common Shares?

The market capitalization of Denium Therapeutics, Inc - Common Shares is 573.91M

How many shares of Denium Therapeutics, Inc - Common Shares are outstanding?

Denium Therapeutics, Inc - Common Shares has 574M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.